• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Thermo Fisher, Verily on FDA list of COVID-19 tests affected by omicron variant

cafead

Administrator
Staff member
  • cafead   Dec 07, 2021 at 11:32: AM
via FDA on Friday published a list of molecular tests for COVID-19 that may be affected by mutations in the omicron variant of concern that continues to spread across the globe.
The agency's list focuses on coronavirus tests impacted by S-gene drop out, an occurrence that is most commonly associated with Thermo Fisher Scientific's TaqPath test kits. When TaqPath is used on a variant with a deletion in the spike gene, such as alph

article source